Macrophage migration inhibitory factor promotes clearance of pneumococcal colonization

Journal of Immunology

Volumn 193, Issue 2, 2014, Pages 764-772

  Das, Rituparna ^a   LaRose, Meredith I ^a   Hergott, Christopher B ^a   Leng, Lin ^b   Bucala, Richard ^b   Weiser, Jeffrey N ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; MITOGEN ACTIVATED PROTEIN KINASE;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM CULTURE; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; DISEASE PREDISPOSITION; GENETIC DIFFERENCE; GENETIC POLYMORPHISM; INNATE IMMUNITY; MACROPHAGE MIGRATION INHIBITION; MOUSE; NASOPHARYNX; NONHUMAN; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SEROTYPE; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; UPPER RESPIRATORY TRACT; UPREGULATION; WILD TYPE;

ANIMALS; BACTERIAL PROTEINS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELLS, CULTURED; CHEMOKINE CCL2; FLOW CYTOMETRY; GENE EXPRESSION; HOST-PATHOGEN INTERACTIONS; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUTATION; NASOPHARYNX; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PNEUMONIA, PNEUMOCOCCAL; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STREPTOCOCCUS PNEUMONIAE; STREPTOLYSINS; TIME FACTORS;

EID: 84904254498     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1400133     Document Type: Article

References (59)

1. O'Brien, K. L., L. J. Wolfson, J. P. Watt, E. Henkle, M. Deloria-Knoll, N. McCall, E. Lee, K. Mulholland, O. S. Levine, and T. Cherian. 2009. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 374: 893-902.
2. Centers for Disease Control and Prevention. 2010. Active Bacterial Core Surveillance (ABCs) Report-Emerging Infections Program Network: Streptococcus pneumoniae. Centers for Disease Control and Prevention, Atlanta, GA.
3. Jackson, L. A., K. M. Neuzil, O. Yu, P. Benson, W. E. Barlow, A. L. Adams, C. A. Hanson, L. D. Mahoney, D. K. Shay, and W. W. Thompson. 2003. Effectiveness of pneumococcal polysaccharide vaccine in older adults. N. Engl. J. Med. 348: 1747-1755. (Pubitemid 36514705)
4. Bogaert, D., R. De Groot, and P. W. Hermans. 2004. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect. Dis. 4: 144-154. (Pubitemid 38293138)
5. Albrich, W. C., S. A. Madhi, P. V. Adrian, N. van Niekerk, T. Mareletsi, C. Cutland, M. Wong, M. Khoosal, A. Karstaedt, P. Zhao, et al. 2012. Use of a rapid test of pneumococcal colonization density to diagnose pneumococcal pneumonia. Clin. Infect. Dis. 54: 601-609.
6. Gray, B. M., G. M. Converse, III, and H. C. Dillon, Jr. 1980. Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life. J. Infect. Dis. 142: 923-933. (Pubitemid 11153261)
7. McCool, T. L., T. R. Cate, G. Moy, and J. N.Weiser. 2002. The immune response to pneumococcal proteins during experimental human carriage. J. Exp. Med. 195: 359-365. (Pubitemid 34461494)
8. McCool, T. L., and J. N. Weiser. 2004. Limited role of antibody in clearance of Streptococcus pneumoniae in a murine model of colonization. Infect. Immun. 72: 5807-5813. (Pubitemid 39303692)
9. Madhi, S. A., P. Adrian, L. Kuwanda, C. Cutland, W. C. Albrich, and K. P. Klugman. 2007. Long-term effect of pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae - and associated interactions with Staphylococcus aureus and Haemophilus influenzae colonization - in HIV-Infected and HIV-uninfected children. J. Infect. Dis. 196: 1662-1666. (Pubitemid 351411964)
10. Lu, Y. J., J. Gross, D. Bogaert, A. Finn, L. Bagrade, Q. Zhang, J. K. Kolls, A. Srivastava, A. Lundgren, S. Forte, et al. 2008. Interleukin-17A mediates acquired immunity to pneumococcal colonization. PLoS Pathog. 4: e1000159.
11. Zhang, Z., T. B. Clarke, and J. N. Weiser. 2009. Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice. J. Clin. Invest. 119: 1899-1909.
12. Nelson, A. L., A. M. Roche, J. M. Gould, K. Chim, A. J. Ratner, and J. N. Weiser. 2007. Capsule enhances pneumococcal colonization by limiting mucus-mediated clearance. Infect. Immun. 75: 83-90. (Pubitemid 46047881)
13. Matthias, K. A., A. M. Roche, A. J. Standish, M. Shchepetov, and J. N. Weiser. 2008. Neutrophil-toxin interactions promote antigen delivery and mucosal clearance of Streptococcus pneumoniae. J. Immunol. 180: 6246-6254.
14. Davis, K. M., S. Nakamura, and J. N. Weiser. 2011. Nod2 sensing of lysozyme-digested peptidoglycan promotes macrophage recruitment and clearance of S. pneumoniae colonization in mice. J. Clin. Invest. 121: 3666-3676.
15. Picard, C., A. Puel, J. Bustamante, C. L. Ku, and J. L. Casanova. 2003. Primary immunodeficiencies associated with pneumococcal disease. Curr. Opin. Allergy Clin. Immunol. 3: 451-459. (Pubitemid 39149558)
16. Burton, D. C., B. Flannery, N. M. Bennett, M. M. Farley, K. Gershman, L. H. Harrison, R. Lynfield, S. Petit, A. L. Reingold, W. Schaffner, et al. 2010. Socioeconomic and racial/ethnic disparities in the incidence of bacteremic pneumonia among US adults. Am. J. Public Health 100: 1904-1911.
17. Brouwer, M. C., J. de Gans, S. G. Heckenberg, A. H. Zwinderman, T. van der Poll, and D. van de Beek. 2009. Host genetic susceptibility to pneumococcal and meningococcal disease: a systematic review and meta-analysis. Lancet Infect. Dis. 9: 31-44.
18. Vuononvirta, J., L. Toivonen, K. Gröndahl-Yli-Hannuksela, A. M. Barkoff, L. Lindholm, J. Mertsola, V. Peltola, and Q. He. 2011. Nasopharyngeal bacterial colonization and gene polymorphisms of mannose-binding lectin and Toll-like receptors 2 and 4 in infants. PLoS One 6: e26198.
19. Yende, S., D. C. Angus, L. Kong, J. A. Kellum, L. Weissfeld, R. Ferrell, D. Finegold, M. Carter, L. Leng, Z. Y. Peng, and R. Bucala. 2009. The influence of macrophage migration inhibitory factor gene polymorphisms on outcome from community-acquired pneumonia. FASEB J. 23: 2403-2411.
20. Sreih, A., R. Ezzeddine, L. Leng, A. LaChance, G. Yu, Y. Mizue, L. Subrahmanyan, B. A. Pons-Estel, A. K. Abelson, I. Gunnarsson, et al. 2011. Dual effect of the macrophage migration inhibitory factor gene on the development and severity of human systemic lupus erythematosus. Arthritis Rheum. 63: 3942-3951.
21. Das, R., L. Subrahmanyan, I. V. Yang, D. van Duin, R. Levy, M. Piecychna, L. Leng, R. R. Montgomery, A. Shaw, D. A. Schwartz, and R. Bucala. 2014. Functional polymorphisms in the gene encoding macrophage migration inhibitory factor are associated with Gram-negative bacteremia in older adults. J. Infect. Dis. 209: 764-768.
22. Das, R., M. S. Koo, B. H. Kim, S. T. Jacob, S. Subbian, J. Yao, L. Leng, R. Levy, C. Murchison, W. J. Burman, et al. 2013. Macrophage migration inhibitory factor (MIF) is a critical mediator of the innate immune response to Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 110: E2997-E3006.
23. Renner, P., T. Roger, P. Y. Bochud, T. Sprong, F. C. Sweep, M. Bochud, S. N. Faust, E. Haralambous, H. Betts, A. L. Chanson, et al. 2012. A functional microsatellite of the macrophage migration inhibitory factor gene associated with meningococcal disease. FASEB J. 26: 907-916.
24. David, J. R. 1966. Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc. Natl. Acad. Sci. USA 56: 72-77.
25. Bloom, B. R., and B. Bennett. 1966. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 153: 80-82.
26. Calandra, T., J. Bernhagen, R. A. Mitchell, and R. Bucala. 1994. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J. Exp. Med. 179: 1895-1902. (Pubitemid 24155670)
27. Bacher, M., A. Meinhardt, H. Y. Lan, W. Mu, C. N. Metz, J. A. Chesney, T. Calandra, D. Gemsa, T. Donnelly, R. C. Atkins, and R. Bucala. 1997. Migration inhibitory factor expression in experimentally induced endotoxemia. Am. J. Pathol. 150: 235-246. (Pubitemid 27027113)
28. Roger, T., J. David, M. P. Glauser, and T. Calandra. 2001. MIF regulates innate immune responses through modulation of Toll-like receptor 4. Nature 414: 920-924. (Pubitemid 34024744)
29. Roger, T., J. Delaloye, A. L. Chanson, M. Giddey, D. Le Roy, and T. Calandra. 2013. Macrophage migration inhibitory factor deficiency is associated with impaired killing of Gram-negative bacteria by macrophages and increased susceptibility to Klebsiella pneumoniae sepsis. J. Infect. Dis. 207: 331-339.
30. Mitchell, R. A., C. N. Metz, T. Peng, and R. Bucala. 1999. Sustained mitogen-activated protein kinase (MAPK) and cytoplasmic phospholipase A2 activation by macrophage migration inhibitory factor (MIF): regulatory role in cell proliferation and glucocorticoid action. J. Biol. Chem. 274: 18100-18106.
31. Daun, J. M., and J. G. Cannon. 2000. Macrophage migration inhibitory factor antagonizes hydrocortisone-induced increases in cytosolic IkBa. Am. J. Physiol. Regul. Integr. Comp. Physiol. 279: R1043-R1049.
32. Mitchell, R. A., H. Liao, J. Chesney, G. Fingerle-Rowson, J. Baugh, J. David, and R. Bucala. 2002. Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response. Proc. Natl. Acad. Sci. USA 99: 345-350. (Pubitemid 34060365)
33. Koebernick, H., L. Grode, J. R. David,W. Rohde, M. S. Rolph, H.W. Mittrücker, and S. H. Kaufmann. 2002. Macrophage migration inhibitory factor (MIF) plays a pivotal role in immunity against Salmonella typhimurium. Proc. Natl. Acad. Sci. USA 99: 13681-13686. (Pubitemid 35215441)
34. Calandra, T., L. A. Spiegel, C. N. Metz, and R. Bucala. 1998. Macrophage migration inhibitory factor is a critical mediator of the activation of immune cells by exotoxins of Gram-positive bacteria. Proc. Natl. Acad. Sci. USA 95: 11383-11388. (Pubitemid 28450137)
35. Cantey, J. R., and W. L. Hand. 1974. Cell-mediated immunity after bacterial infection of the lower respiratory tract. J. Clin. Invest. 54: 1125-1134.
36. Roche, A. M., S. J. King, and J. N. Weiser. 2007. Live attenuated Streptococcus pneumoniae strains induce serotype-independent mucosal and systemic protection in mice. Infect. Immun. 75: 2469-2475. (Pubitemid 46744338)
37. Wu, H. Y., A. Virolainen, B. Mathews, J. King, M. W. Russell, and D. E. Briles. 1997. Establishment of a Streptococcus pneumoniae nasopharyngeal colonization model in adult mice. Microb. Pathog. 23: 127-137. (Pubitemid 27387531)
38. Bernhagen, J., R. A. Mitchell, T. Calandra, W. Voelter, A. Cerami, and R. Bucala. 1994. Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF). Biochemistry 33: 14144-14155. (Pubitemid 24382359)
39. van Rossum, A. M., E. S. Lysenko, and J. N. Weiser. 2005. Host and bacterial factors contributing to the clearance of colonization by Streptococcus pneumoniae in a murine model. Infect. Immun. 73: 7718-7726.
40. Malley, R., P. Henneke, S. C. Morse, M. J. Cieslewicz, M. Lipsitch, C. M. Thompson, E. Kurt-Jones, J. C. Paton, M. R.Wessels, and D. T. Golenbock. 2003. Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection. Proc. Natl. Acad. Sci. USA 100: 1966-1971. (Pubitemid 36254557)
41. McNeela, E. A., A. Burke, D. R. Neill, C. Baxter, V. E. Fernandes, D. Ferreira, S. Smeaton, R. El-Rachkidy, R. M. McLoughlin, A. Mori, et al. 2010. Pneumolysin activates the NLRP3 inflammasome and promotes proinflammatory cytokines independently of TLR4. PLoS Pathog. 6: e1001191.
42. Witzenrath, M., F. Pache, D. Lorenz, U. Koppe, B. Gutbier, C. Tabeling, K. Reppe, K. Meixenberger, A. Dorhoi, J. Ma, et al. 2011. The NLRP3 inflammasome is differentially activated by pneumolysin variants and contributes to host defense in pneumococcal pneumonia. J. Immunol. 187: 434-440.
43. Ratner, A. J., K. R. Hippe, J. L. Aguilar, M. H. Bender, A. L. Nelson, and J. N. Weiser. 2006. Epithelial cells are sensitive detectors of bacterial poreforming toxins. J. Biol. Chem. 281: 12994-12998. (Pubitemid 43855393)
44. Aeberli, D., Y. Yang, A. Mansell, L. Santos, M. Leech, and E. F. Morand. 2006. Endogenous macrophage migration inhibitory factor modulates glucocorticoid sensitivity in macrophages via effects on MAP kinase phosphatase-1 and p38 MAP kinase. FEBS Lett. 580: 974-981. (Pubitemid 43152322)
45. Temple, S. E., K. Y. Cheong, P. Price, and G. W. Waterer. 2008. The microsatellite, macrophage migration inhibitory factor -794, may influence gene expression in human mononuclear cells stimulated with E. coli or S. pneumoniae. Int. J. Immunogenet. 35: 309-316.
46. Ferreira, D. M., D. R. Neill, M. Bangert, J. F. Gritzfeld, N. Green, A. K. Wright, S. H. Pennington, L. Bricio-Moreno, A. T. Moreno, E. N. Miyaji, et al. 2013. Controlled human infection and rechallenge with Streptococcus pneumoniae reveals the protective efficacy of carriage in healthy adults. Am. J. Respir. Crit. Care Med. 187: 855-864.
47. Lehmann, L. E., M. Book, W. Hartmann, S. U. Weber, J. C. Schewe, S. Klaschik, A. Hoeft, and F. Stüber. 2009. A MIF haplotype is associated with the outcome of patients with severe sepsis: a case control study. J. Transl. Med. 7: 100.
48. Bozza, M., A. R. Satoskar, G. Lin, B. Lu, A. A. Humbles, C. Gerard, and J. R. David. 1999. Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis. J. Exp. Med. 189: 341-346. (Pubitemid 29063255)
49. Plant, B. J., C. G. Gallagher, R. Bucala, J. A. Baugh, S. Chappell, L. Morgan, C. M. O'Connor, K. Morgan, and S. C. Donnelly. 2005. Cystic fibrosis, disease severity, and a macrophage migration inhibitory factor polymorphism. Am. J. Respir. Crit. Care Med. 172: 1412-1415. (Pubitemid 43069814)
50. Doernberg, S., B. Schaaf, K. Dalhoff, L. Leng, A. Beitin, V. Quagliarello, and R. Bucala. 2011. Association of macrophage migration inhibitory factor (MIF) polymorphisms with risk of meningitis from Streptococcus pneumoniae. Cytokine 53: 292-294.
51. Guilliams, M., I. De Kleer, S. Henri, S. Post, L. Vanhoutte, S. De Prijck, K. Deswarte, B. Malissen, H. Hammad, and B. N. Lambrecht. 2013. Alveolar macrophages develop from fetal monocytes that differentiate into long-lived cells in the first week of life via GM-CSF. J. Exp. Med. 210: 1977-1992.
52. Gregory, J. L., E. F. Morand, S. J. McKeown, J. A. Ralph, P. Hall, Y. H. Yang, S. R. McColl, and M. J. Hickey. 2006. Macrophage migration inhibitory factor induces macrophage recruitment via CC chemokine ligand 2. J. Immunol. 177: 8072-8079. (Pubitemid 44846325)
53. Berry, A. M., J. Yother, D. E. Briles, D. Hansman, and J. C. Paton. 1989. Reduced virulence of a defined pneumolysin-negative mutant of Streptococcus pneumoniae. Infect. Immun. 57: 2037-2042. (Pubitemid 19186880)
54. Beisswenger, C., C. B. Coyne, M. Shchepetov, and J. N. Weiser. 2007. Role of p38 MAP kinase and transforming growth factor-β signaling in transepithelial migration of invasive bacterial pathogens. J. Biol. Chem. 282:28700-28708. (Pubitemid 47606066)
55. Bebien, M., M. E. Hensler, S. Davanture, L. C. Hsu, M. Karin, J. M. Park, L. Alexopoulou, G. Y. Liu, V. Nizet, and T. Lawrence. 2012. The pore-forming toxin β hemolysin/cytolysin triggers p38 MAPK-dependent IL-10 production in macrophages and inhibits innate immunity. PLoS Pathog. 8: e1002812.
56. Roger, T., X. Ding, A. L. Chanson, P. Renner, and T. Calandra. 2007. Regulation of constitutive and microbial pathogen-induced human macrophage migration inhibitory factor (MIF) gene expression. Eur. J. Immunol. 37: 3509-3521.
57. Weiser, J. N. 2010. The pneumococcus: why a commensal misbehaves. J. Mol. Med. 88: 97-102.
58. Maaser, C., L. Eckmann, G. Paesold, H. S. Kim, and M. F. Kagnoff. 2002. Ubiquitous production of macrophage migration inhibitory factor by human gastric and intestinal epithelium. Gastroenterology 122: 667-680. (Pubitemid 34173819)
59. Fehlings, M., L. Drobbe, V. Moos, P. Renner Viveros, J. Hagen, M. Beigier-Bompadre, E. Pang, E. Belogolova, Y. Churin, T. Schneider, et al. 2012. Comparative analysis of the interaction of Helicobacter pylori with human dendritic cells, macrophages, and monocytes. Infect. Immun. 80: 2724-2734.